Everest Organics, a company in the Pharmaceuticals industry, reported revenue of ₹48 crore and net profit of ₹0.80 crore for the September 2026 quarter.
Everest Organics (BSE: EVERESTO) closed at ₹219.40 on 20 Nov 2026, down 52.1% over the past year. Its market capitalisation is ₹219 crore and it trades at 44.6 times earnings.
Everest Organics Ltd (EOL) makes active pharmaceutical ingredients (APIs), the main medicinal ingredients in finished medicines, and chemical intermediates used to make APIs. Its factory is at Aroor, Sangareddy, Telangana.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.